Interventional Oncology Solutions
Market Regional Analysis:-
North America is expected to hold
dominant position in the global Interventional
Oncology Solutions Market over the forecast period. This is owing to
increasing mergers & acquisition and research collaboration between
manufacturers and universities in the region to develop novel products. For
instance, in 2015, Boston Scientific enhanced its interventional oncology
portfolio by acquiring spherical embolic technologies, Embozene and Oncozene
microspheres, which were developed by Celo Nova Biosciences. These spheres are
designed to prevent flow of blood to the targeted tissue and also reduce growth
of tumors. Moreover, in 2016, Philips collaborated with Yale School of Medicine
to bring new innovations in the field of interventional oncology. Liver cancer
is one of their main focus areas, as TACE (Trans arterial Chemoembolization),
an alternative and minimally invasive technique to treat liver cancer patients,
it has shown better results than chemotherapy. TACE is a minimally invasive
procedure which is performed in interventional radiology to restrict a tumors
blood supply. Small embolic particles which are coated with chemotherapeutic
drugs are injected through a catheter into the arteries which supply blood to
the tumor. Chemotherapeutic drugs block the supply of blood and induce
cytotoxicity i.e. attacking the tumor in several ways. TACE involves administration
of embolic beads and chemotherapy agents to gradually block arteries feeding
the tumor, which further causes death of the tumor.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1884
Interventional oncology is a
field of medical science, which includes treatment and diagnosis of cancer and
other problems related to cancer using minimally invasive procedures.
Interventional oncology uses various techniques such as Ultrasound, computed
tomography, X-ray, and magnetic resonance imaging (MRI) to treat tumors located
in various organs of the body. Interventional oncology procedures are usually
used to treat metastatic or primary cancer. These procedures can be used to
treat cancer in pancreas, liver, lung, breast, prostrate, kidney, and bones.
Interventional oncology procedures are segmented into two procedures i.e.
diagnostic and therapeutic. Therapeutic procedures can be further categorized
into ablation techniques and embolization techniques. Ablation techniques uses
some form of heat to destroy tumor. Embolization Technique occludes blood
vessels, which feed tumors and further destroy the tumor by means of ischemia.
Both these procedures are minimally invasive and there is minimal pain,
complications, and discomfort with rapid recovery.
Interventional Oncology Solutions
Market Drivers:-
Increasing popularity of minimal
invasive procedures due to advantages such as minimal risk of infection,
shorter stay in the hospitals, minimal complications, minimal pain, and faster
recovery as compared to invasive surgeries, is a major factor supporting the
global interventional oncology solutions market growth over the forecast
period. Moreover, increasing product launches is expected to aid in growth in
interventional oncology solutions market size. For instance, in 2017, Terumo
Corporation, a Japan-based company, launched Quirem Spheres microspheres. This
is used to treat solid liver tumors, which cannot be removed by surgery
completely. Microspheres consists of a radioactive isotope Holium-166. Quirem
Spheres and can also be visualized in low concentrations by means of SPECT
(Single Photon Emission Computed Tomography) and MRI. This feature allows
doctors to carefully assess distribution of microspheres in the organs such as
liver, which enables in accurate assessment of treatment after SIRT (Selective
Internal radiation Therapy) procedure. Half-life of Quirem Spheres is 26.8
hours, which means that within the first 4 days more than 90% of the radiation
is delivered, which is followed by implantation procedure.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/interventional-oncology-solutions-market-1884
Europe interventional oncology
solutions market is expected to exhibit high growth over the forecast period,
owing to high cancer prevalence in the region. According to a study conducted
by World Health Organization (WHO) in 2016, Europe has over 753,600 people
diagnosed with cancer. Furthermore, key players in the region are focusing on
launching new products, which is another factor supporting growth of the
market. For instance, in 2017, Elekta, a Sweden-based company, launched Elekta
Unity MR-linac, which relies on a Philips 1.5 Tesla MRI Machine. During therapy
sessions, the machine produces diagnostic level image quality. This device
provides more precise treatment, which includes targeting of higher doses on sensitive
areas containing multiple organs and also observation of radiation affecting
tumor. One of the most important application of this device is the functional
MRI, which helps doctor to observe how the treatment is working on the tumor
and it also helps to evaluate the rate of blood flow through the tumor, which
indicates if the tissue is alive or is showing some change due to the therapy.
Interventional Oncology Solutions
Market Key Players:-
Key players operating in the
global interventional oncology solutions market include Boston Scientific
Corporation, Angio Dynamics, C.R. Bard, Best Medical International, Pfizer,
MedWaves, Health Tronics, Sitex, BTG, Merit Medical Systems, Perseon, Cook
Medical, Accuracy, Vascular Solutions, TERUMO, ALPINION MEDICAL SYSTEMS, Varian
medical, Smith & Nephew, Profound Medical, BOVIE MEDICAL, and Baylis
Medical.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1884
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment